These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes]. Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537 [TBL] [Abstract][Full Text] [Related]
24. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
25. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Rolston KV Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020 [TBL] [Abstract][Full Text] [Related]
26. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit. Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450 [TBL] [Abstract][Full Text] [Related]
27. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study. Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H; Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952 [TBL] [Abstract][Full Text] [Related]
28. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections. Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056 [TBL] [Abstract][Full Text] [Related]
29. Is double coverage of gram-negative organisms necessary? Johnson SJ; Ernst EJ; Moores KG Am J Health Syst Pharm; 2011 Jan; 68(2):119-24. PubMed ID: 21200057 [TBL] [Abstract][Full Text] [Related]
30. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy. Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420 [TBL] [Abstract][Full Text] [Related]
31. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Rahal JJ Clin Infect Dis; 2006 Sep; 43 Suppl 2():S95-9. PubMed ID: 16894522 [TBL] [Abstract][Full Text] [Related]
32. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome. Hamzeh F; Kanj SS; Uwaydah M J Med Liban; 2000; 48(3):136-42. PubMed ID: 11268566 [TBL] [Abstract][Full Text] [Related]
33. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
34. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with antibiotics in the treatment of febrile neutropenia in children. Riikonen P Stem Cells; 1995 May; 13(3):201-5. PubMed ID: 7613488 [TBL] [Abstract][Full Text] [Related]
35. [Penicillin and aminoglycoside in febrile neutropenia]. Torfoss D; Høiby EA; Holte H; Kvaløy S Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2738-40. PubMed ID: 19079423 [TBL] [Abstract][Full Text] [Related]
36. The role of schedule of antibiotic therapy on the neutropenic patient. Bodey GP; Valdivieso M; Yap BS Infection; 1980; Suppl 1():75-81. PubMed ID: 7399718 [No Abstract] [Full Text] [Related]
37. [Prevention and treatment of neutropenia. Practical procedures]. Bergheim J Tidsskr Nor Laegeforen; 1990 Mar; 110(9):1115-6. PubMed ID: 2330573 [No Abstract] [Full Text] [Related]